• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AMGA Releases Population Health Framework to Improve ASCVD Secondary Prevention

Press Release
Article

Proven interventions to improve care, address disparities, and support lipid management are woven throughout AMGA Foundation's new framework to guide population health–based secondary prevention strategies for atherosclerotic cardiovascular disease (ASCVD).

Alexandria, Virginia — “Population Health Approach to Secondary Prevention for ASCVD Framework and Infographic" is a new offering from the AMGA Foundation, whose goal is to improve health care within the US through population health and quality initiatives.

Through its ASCVD Best Practices Learning Collaborative, the AMGA Foundation worked with 12 health care organizations to address the management and treatment of atherosclerotic cardiovascular disease (ASCVD), identifying both successes and challenges to best inform strategies targeted at improving patient care and outcomes. The main goals of the report are to provide a practical, evidence-based framework for improving the secondary prevention and management of ASCVD and to support health care organizations in implementing proven interventions that enhance clinical decision-making, promote team-based care, address health disparities, and improve lipid management and patient adherence.

In ASCVD, plaques attach and build up in arterial walls, and have potential to cause damaging, if not deadly, heart attacks, stroke, and aortic atherosclerotic disease.

John W. Kennedy, MD | Image Credit: © AMGA Foundation

John W. Kennedy, MD | Image Credit: © AMGA Foundation

"ASCVD is a major contributor to cardiovascular disease, the leading cause of death in the United States. Collaborative participating groups made great progress in implementing interventions identified for successful patient care in secondary prevention of ASCVD,” said John Kennedy, MD, AMGA Foundation president and AMGA chief medical officer, in a press release announcing the report. “Using these learnings and applying a population health approach, we can contribute to improved care for millions of patients living with ASCVD.”

Click to learn more about the report and the AMGA Foundation.

Related Videos
David Awad, PharmD, BCOP
Merrill H. Stewart, MD
Andrew Evens, DO, MBA, MSc, deputy director for clinical services and chief physician officer, Rutgers Cancer Institute and Jack & Sheryl Morris Cancer Center
Hamlet Gasoyan, PhD
Dr Matthew Matasar
Dr Marina Kremskayana
Dr Sundar Jagannath
David Awad, PharmD, BCOP
Andrew Kuykendall, MD, Moffitt Cancer Center
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.